BOLD Should I Buy

Not a good buy right now for a beginner long-term investor with $50k–$100k who doesn’t want to wait for better entries. Boundless Bio is a pre-revenue biotech with widening losses, no near-term catalysts in the provided news, and bearish-to-weak technical momentum around key support. I would avoid initiating a position at this time (hold/skip).

Price/levels: Current price ~$1.20, sitting directly on S1 support (1.20). Next support S2 is 1.165; overhead pivot/resistance is 1.257 then 1.315. Trend/momentum: MACD histogram is negative (-0.00534) and expanding lower, which indicates bearish momentum is strengthening. RSI(6) ~38 is weak (near oversold but not showing a clear reversal signal). Moving averages are converging, suggesting consolidation rather than a confirmed uptrend. Pattern/near-term probabilities: Similar-pattern model implies mild upside over the next week (+1.92%) but slightly negative next month (-0.28%), consistent with choppy, non-trending action near support. **Intellectia Proprietary Trading Signals** - [AI Stock Picker](module://ai_stock_pick): no signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock recently.